Global Sepsis Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Sepsis Diagnostics market size was valued at USD 371 million in 2023 and is forecast to a readjusted size of USD 521.2 million by 2030 with a CAGR of 5.0% during review period.
Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.
Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.
North America is expected to command the largest share of the market in 2018, due to the growing prevalence of sepsis, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.
The Global Info Research report includes an overview of the development of the Sepsis Diagnostics industry chain, the market status of Hospitals (Microbiology, Molecular Diagnostics), Pathology & Reference Laboratories (Microbiology, Molecular Diagnostics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Sepsis Diagnostics.
Regionally, the report analyzes the Sepsis Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Sepsis Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Sepsis Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Sepsis Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Microbiology, Molecular Diagnostics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Sepsis Diagnostics market.
Regional Analysis: The report involves examining the Sepsis Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Sepsis Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Sepsis Diagnostics:
Company Analysis: Report covers individual Sepsis Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Sepsis Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Pathology & Reference Laboratories).
Technology Analysis: Report covers specific technologies relevant to Sepsis Diagnostics. It assesses the current state, advancements, and potential future developments in Sepsis Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Sepsis Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Sepsis Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Sepsis Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Sepsis Diagnostics, with revenue, gross margin and global market share of Sepsis Diagnostics from 2019 to 2024.
Chapter 3, the Sepsis Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Sepsis Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sepsis Diagnostics.
Chapter 13, to describe Sepsis Diagnostics research findings and conclusion.
Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.
Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.
North America is expected to command the largest share of the market in 2018, due to the growing prevalence of sepsis, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.
The Global Info Research report includes an overview of the development of the Sepsis Diagnostics industry chain, the market status of Hospitals (Microbiology, Molecular Diagnostics), Pathology & Reference Laboratories (Microbiology, Molecular Diagnostics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Sepsis Diagnostics.
Regionally, the report analyzes the Sepsis Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Sepsis Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Sepsis Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Sepsis Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Microbiology, Molecular Diagnostics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Sepsis Diagnostics market.
Regional Analysis: The report involves examining the Sepsis Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Sepsis Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Sepsis Diagnostics:
Company Analysis: Report covers individual Sepsis Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Sepsis Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Pathology & Reference Laboratories).
Technology Analysis: Report covers specific technologies relevant to Sepsis Diagnostics. It assesses the current state, advancements, and potential future developments in Sepsis Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Sepsis Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Sepsis Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Microbiology
- Molecular Diagnostics
- Immunoassays
- Flow Cytometry
- Microfluidics
- Biomarkers
- Hospitals
- Pathology & Reference Laboratories
- Biomerieux
- T2 Biosystems
- Luminex
- Becton, Dickinson
- Roche
- Danaher
- Thermo Fisher
- Bruker
- Abbott
- Immunexpress
- Response Biomedical
- Axis-Shield Diagnostics
- Cytosorbents
- Mitsubishi Chemical
- EKF Diagnostics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Sepsis Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Sepsis Diagnostics, with revenue, gross margin and global market share of Sepsis Diagnostics from 2019 to 2024.
Chapter 3, the Sepsis Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Sepsis Diagnostics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sepsis Diagnostics.
Chapter 13, to describe Sepsis Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Sepsis Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Sepsis Diagnostics by Type
1.3.1 Overview: Global Sepsis Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Sepsis Diagnostics Consumption Value Market Share by Type in 2023
1.3.3 Microbiology
1.3.4 Molecular Diagnostics
1.3.5 Immunoassays
1.3.6 Flow Cytometry
1.3.7 Microfluidics
1.3.8 Biomarkers
1.4 Global Sepsis Diagnostics Market by Application
1.4.1 Overview: Global Sepsis Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Pathology & Reference Laboratories
1.5 Global Sepsis Diagnostics Market Size & Forecast
1.6 Global Sepsis Diagnostics Market Size and Forecast by Region
1.6.1 Global Sepsis Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Sepsis Diagnostics Market Size by Region, (2019-2030)
1.6.3 North America Sepsis Diagnostics Market Size and Prospect (2019-2030)
1.6.4 Europe Sepsis Diagnostics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Sepsis Diagnostics Market Size and Prospect (2019-2030)
1.6.6 South America Sepsis Diagnostics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Sepsis Diagnostics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Biomerieux
2.1.1 Biomerieux Details
2.1.2 Biomerieux Major Business
2.1.3 Biomerieux Sepsis Diagnostics Product and Solutions
2.1.4 Biomerieux Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Biomerieux Recent Developments and Future Plans
2.2 T2 Biosystems
2.2.1 T2 Biosystems Details
2.2.2 T2 Biosystems Major Business
2.2.3 T2 Biosystems Sepsis Diagnostics Product and Solutions
2.2.4 T2 Biosystems Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 T2 Biosystems Recent Developments and Future Plans
2.3 Luminex
2.3.1 Luminex Details
2.3.2 Luminex Major Business
2.3.3 Luminex Sepsis Diagnostics Product and Solutions
2.3.4 Luminex Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Luminex Recent Developments and Future Plans
2.4 Becton, Dickinson
2.4.1 Becton, Dickinson Details
2.4.2 Becton, Dickinson Major Business
2.4.3 Becton, Dickinson Sepsis Diagnostics Product and Solutions
2.4.4 Becton, Dickinson Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Becton, Dickinson Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Sepsis Diagnostics Product and Solutions
2.5.4 Roche Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Roche Recent Developments and Future Plans
2.6 Danaher
2.6.1 Danaher Details
2.6.2 Danaher Major Business
2.6.3 Danaher Sepsis Diagnostics Product and Solutions
2.6.4 Danaher Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Danaher Recent Developments and Future Plans
2.7 Thermo Fisher
2.7.1 Thermo Fisher Details
2.7.2 Thermo Fisher Major Business
2.7.3 Thermo Fisher Sepsis Diagnostics Product and Solutions
2.7.4 Thermo Fisher Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Thermo Fisher Recent Developments and Future Plans
2.8 Bruker
2.8.1 Bruker Details
2.8.2 Bruker Major Business
2.8.3 Bruker Sepsis Diagnostics Product and Solutions
2.8.4 Bruker Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bruker Recent Developments and Future Plans
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Sepsis Diagnostics Product and Solutions
2.9.4 Abbott Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Abbott Recent Developments and Future Plans
2.10 Immunexpress
2.10.1 Immunexpress Details
2.10.2 Immunexpress Major Business
2.10.3 Immunexpress Sepsis Diagnostics Product and Solutions
2.10.4 Immunexpress Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Immunexpress Recent Developments and Future Plans
2.11 Response Biomedical
2.11.1 Response Biomedical Details
2.11.2 Response Biomedical Major Business
2.11.3 Response Biomedical Sepsis Diagnostics Product and Solutions
2.11.4 Response Biomedical Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Response Biomedical Recent Developments and Future Plans
2.12 Axis-Shield Diagnostics
2.12.1 Axis-Shield Diagnostics Details
2.12.2 Axis-Shield Diagnostics Major Business
2.12.3 Axis-Shield Diagnostics Sepsis Diagnostics Product and Solutions
2.12.4 Axis-Shield Diagnostics Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Axis-Shield Diagnostics Recent Developments and Future Plans
2.13 Cytosorbents
2.13.1 Cytosorbents Details
2.13.2 Cytosorbents Major Business
2.13.3 Cytosorbents Sepsis Diagnostics Product and Solutions
2.13.4 Cytosorbents Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Cytosorbents Recent Developments and Future Plans
2.14 Mitsubishi Chemical
2.14.1 Mitsubishi Chemical Details
2.14.2 Mitsubishi Chemical Major Business
2.14.3 Mitsubishi Chemical Sepsis Diagnostics Product and Solutions
2.14.4 Mitsubishi Chemical Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Mitsubishi Chemical Recent Developments and Future Plans
2.15 EKF Diagnostics
2.15.1 EKF Diagnostics Details
2.15.2 EKF Diagnostics Major Business
2.15.3 EKF Diagnostics Sepsis Diagnostics Product and Solutions
2.15.4 EKF Diagnostics Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 EKF Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Sepsis Diagnostics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Sepsis Diagnostics by Company Revenue
3.2.2 Top 3 Sepsis Diagnostics Players Market Share in 2023
3.2.3 Top 6 Sepsis Diagnostics Players Market Share in 2023
3.3 Sepsis Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Sepsis Diagnostics Market: Region Footprint
3.3.2 Sepsis Diagnostics Market: Company Product Type Footprint
3.3.3 Sepsis Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Sepsis Diagnostics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Sepsis Diagnostics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Sepsis Diagnostics Consumption Value Market Share by Application (2019-2024)
5.2 Global Sepsis Diagnostics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Sepsis Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Sepsis Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Sepsis Diagnostics Market Size by Country
6.3.1 North America Sepsis Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Sepsis Diagnostics Market Size and Forecast (2019-2030)
6.3.3 Canada Sepsis Diagnostics Market Size and Forecast (2019-2030)
6.3.4 Mexico Sepsis Diagnostics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Sepsis Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Sepsis Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Sepsis Diagnostics Market Size by Country
7.3.1 Europe Sepsis Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Sepsis Diagnostics Market Size and Forecast (2019-2030)
7.3.3 France Sepsis Diagnostics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Sepsis Diagnostics Market Size and Forecast (2019-2030)
7.3.5 Russia Sepsis Diagnostics Market Size and Forecast (2019-2030)
7.3.6 Italy Sepsis Diagnostics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Sepsis Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Sepsis Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Sepsis Diagnostics Market Size by Region
8.3.1 Asia-Pacific Sepsis Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Sepsis Diagnostics Market Size and Forecast (2019-2030)
8.3.3 Japan Sepsis Diagnostics Market Size and Forecast (2019-2030)
8.3.4 South Korea Sepsis Diagnostics Market Size and Forecast (2019-2030)
8.3.5 India Sepsis Diagnostics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Sepsis Diagnostics Market Size and Forecast (2019-2030)
8.3.7 Australia Sepsis Diagnostics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Sepsis Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Sepsis Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Sepsis Diagnostics Market Size by Country
9.3.1 South America Sepsis Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Sepsis Diagnostics Market Size and Forecast (2019-2030)
9.3.3 Argentina Sepsis Diagnostics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Sepsis Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Sepsis Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Sepsis Diagnostics Market Size by Country
10.3.1 Middle East & Africa Sepsis Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Sepsis Diagnostics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Sepsis Diagnostics Market Size and Forecast (2019-2030)
10.3.4 UAE Sepsis Diagnostics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Sepsis Diagnostics Market Drivers
11.2 Sepsis Diagnostics Market Restraints
11.3 Sepsis Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Sepsis Diagnostics Industry Chain
12.2 Sepsis Diagnostics Upstream Analysis
12.3 Sepsis Diagnostics Midstream Analysis
12.4 Sepsis Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Sepsis Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Sepsis Diagnostics by Type
1.3.1 Overview: Global Sepsis Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Sepsis Diagnostics Consumption Value Market Share by Type in 2023
1.3.3 Microbiology
1.3.4 Molecular Diagnostics
1.3.5 Immunoassays
1.3.6 Flow Cytometry
1.3.7 Microfluidics
1.3.8 Biomarkers
1.4 Global Sepsis Diagnostics Market by Application
1.4.1 Overview: Global Sepsis Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Pathology & Reference Laboratories
1.5 Global Sepsis Diagnostics Market Size & Forecast
1.6 Global Sepsis Diagnostics Market Size and Forecast by Region
1.6.1 Global Sepsis Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Sepsis Diagnostics Market Size by Region, (2019-2030)
1.6.3 North America Sepsis Diagnostics Market Size and Prospect (2019-2030)
1.6.4 Europe Sepsis Diagnostics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Sepsis Diagnostics Market Size and Prospect (2019-2030)
1.6.6 South America Sepsis Diagnostics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Sepsis Diagnostics Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Biomerieux
2.1.1 Biomerieux Details
2.1.2 Biomerieux Major Business
2.1.3 Biomerieux Sepsis Diagnostics Product and Solutions
2.1.4 Biomerieux Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Biomerieux Recent Developments and Future Plans
2.2 T2 Biosystems
2.2.1 T2 Biosystems Details
2.2.2 T2 Biosystems Major Business
2.2.3 T2 Biosystems Sepsis Diagnostics Product and Solutions
2.2.4 T2 Biosystems Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 T2 Biosystems Recent Developments and Future Plans
2.3 Luminex
2.3.1 Luminex Details
2.3.2 Luminex Major Business
2.3.3 Luminex Sepsis Diagnostics Product and Solutions
2.3.4 Luminex Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Luminex Recent Developments and Future Plans
2.4 Becton, Dickinson
2.4.1 Becton, Dickinson Details
2.4.2 Becton, Dickinson Major Business
2.4.3 Becton, Dickinson Sepsis Diagnostics Product and Solutions
2.4.4 Becton, Dickinson Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Becton, Dickinson Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche Sepsis Diagnostics Product and Solutions
2.5.4 Roche Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Roche Recent Developments and Future Plans
2.6 Danaher
2.6.1 Danaher Details
2.6.2 Danaher Major Business
2.6.3 Danaher Sepsis Diagnostics Product and Solutions
2.6.4 Danaher Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Danaher Recent Developments and Future Plans
2.7 Thermo Fisher
2.7.1 Thermo Fisher Details
2.7.2 Thermo Fisher Major Business
2.7.3 Thermo Fisher Sepsis Diagnostics Product and Solutions
2.7.4 Thermo Fisher Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Thermo Fisher Recent Developments and Future Plans
2.8 Bruker
2.8.1 Bruker Details
2.8.2 Bruker Major Business
2.8.3 Bruker Sepsis Diagnostics Product and Solutions
2.8.4 Bruker Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bruker Recent Developments and Future Plans
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Sepsis Diagnostics Product and Solutions
2.9.4 Abbott Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Abbott Recent Developments and Future Plans
2.10 Immunexpress
2.10.1 Immunexpress Details
2.10.2 Immunexpress Major Business
2.10.3 Immunexpress Sepsis Diagnostics Product and Solutions
2.10.4 Immunexpress Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Immunexpress Recent Developments and Future Plans
2.11 Response Biomedical
2.11.1 Response Biomedical Details
2.11.2 Response Biomedical Major Business
2.11.3 Response Biomedical Sepsis Diagnostics Product and Solutions
2.11.4 Response Biomedical Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Response Biomedical Recent Developments and Future Plans
2.12 Axis-Shield Diagnostics
2.12.1 Axis-Shield Diagnostics Details
2.12.2 Axis-Shield Diagnostics Major Business
2.12.3 Axis-Shield Diagnostics Sepsis Diagnostics Product and Solutions
2.12.4 Axis-Shield Diagnostics Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Axis-Shield Diagnostics Recent Developments and Future Plans
2.13 Cytosorbents
2.13.1 Cytosorbents Details
2.13.2 Cytosorbents Major Business
2.13.3 Cytosorbents Sepsis Diagnostics Product and Solutions
2.13.4 Cytosorbents Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Cytosorbents Recent Developments and Future Plans
2.14 Mitsubishi Chemical
2.14.1 Mitsubishi Chemical Details
2.14.2 Mitsubishi Chemical Major Business
2.14.3 Mitsubishi Chemical Sepsis Diagnostics Product and Solutions
2.14.4 Mitsubishi Chemical Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Mitsubishi Chemical Recent Developments and Future Plans
2.15 EKF Diagnostics
2.15.1 EKF Diagnostics Details
2.15.2 EKF Diagnostics Major Business
2.15.3 EKF Diagnostics Sepsis Diagnostics Product and Solutions
2.15.4 EKF Diagnostics Sepsis Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 EKF Diagnostics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Sepsis Diagnostics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Sepsis Diagnostics by Company Revenue
3.2.2 Top 3 Sepsis Diagnostics Players Market Share in 2023
3.2.3 Top 6 Sepsis Diagnostics Players Market Share in 2023
3.3 Sepsis Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Sepsis Diagnostics Market: Region Footprint
3.3.2 Sepsis Diagnostics Market: Company Product Type Footprint
3.3.3 Sepsis Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Sepsis Diagnostics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Sepsis Diagnostics Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Sepsis Diagnostics Consumption Value Market Share by Application (2019-2024)
5.2 Global Sepsis Diagnostics Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Sepsis Diagnostics Consumption Value by Type (2019-2030)
6.2 North America Sepsis Diagnostics Consumption Value by Application (2019-2030)
6.3 North America Sepsis Diagnostics Market Size by Country
6.3.1 North America Sepsis Diagnostics Consumption Value by Country (2019-2030)
6.3.2 United States Sepsis Diagnostics Market Size and Forecast (2019-2030)
6.3.3 Canada Sepsis Diagnostics Market Size and Forecast (2019-2030)
6.3.4 Mexico Sepsis Diagnostics Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Sepsis Diagnostics Consumption Value by Type (2019-2030)
7.2 Europe Sepsis Diagnostics Consumption Value by Application (2019-2030)
7.3 Europe Sepsis Diagnostics Market Size by Country
7.3.1 Europe Sepsis Diagnostics Consumption Value by Country (2019-2030)
7.3.2 Germany Sepsis Diagnostics Market Size and Forecast (2019-2030)
7.3.3 France Sepsis Diagnostics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Sepsis Diagnostics Market Size and Forecast (2019-2030)
7.3.5 Russia Sepsis Diagnostics Market Size and Forecast (2019-2030)
7.3.6 Italy Sepsis Diagnostics Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Sepsis Diagnostics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Sepsis Diagnostics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Sepsis Diagnostics Market Size by Region
8.3.1 Asia-Pacific Sepsis Diagnostics Consumption Value by Region (2019-2030)
8.3.2 China Sepsis Diagnostics Market Size and Forecast (2019-2030)
8.3.3 Japan Sepsis Diagnostics Market Size and Forecast (2019-2030)
8.3.4 South Korea Sepsis Diagnostics Market Size and Forecast (2019-2030)
8.3.5 India Sepsis Diagnostics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Sepsis Diagnostics Market Size and Forecast (2019-2030)
8.3.7 Australia Sepsis Diagnostics Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Sepsis Diagnostics Consumption Value by Type (2019-2030)
9.2 South America Sepsis Diagnostics Consumption Value by Application (2019-2030)
9.3 South America Sepsis Diagnostics Market Size by Country
9.3.1 South America Sepsis Diagnostics Consumption Value by Country (2019-2030)
9.3.2 Brazil Sepsis Diagnostics Market Size and Forecast (2019-2030)
9.3.3 Argentina Sepsis Diagnostics Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Sepsis Diagnostics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Sepsis Diagnostics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Sepsis Diagnostics Market Size by Country
10.3.1 Middle East & Africa Sepsis Diagnostics Consumption Value by Country (2019-2030)
10.3.2 Turkey Sepsis Diagnostics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Sepsis Diagnostics Market Size and Forecast (2019-2030)
10.3.4 UAE Sepsis Diagnostics Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Sepsis Diagnostics Market Drivers
11.2 Sepsis Diagnostics Market Restraints
11.3 Sepsis Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Sepsis Diagnostics Industry Chain
12.2 Sepsis Diagnostics Upstream Analysis
12.3 Sepsis Diagnostics Midstream Analysis
12.4 Sepsis Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Sepsis Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Sepsis Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Sepsis Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Sepsis Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Biomerieux Company Information, Head Office, and Major Competitors
Table 6. Biomerieux Major Business
Table 7. Biomerieux Sepsis Diagnostics Product and Solutions
Table 8. Biomerieux Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Biomerieux Recent Developments and Future Plans
Table 10. T2 Biosystems Company Information, Head Office, and Major Competitors
Table 11. T2 Biosystems Major Business
Table 12. T2 Biosystems Sepsis Diagnostics Product and Solutions
Table 13. T2 Biosystems Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. T2 Biosystems Recent Developments and Future Plans
Table 15. Luminex Company Information, Head Office, and Major Competitors
Table 16. Luminex Major Business
Table 17. Luminex Sepsis Diagnostics Product and Solutions
Table 18. Luminex Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Luminex Recent Developments and Future Plans
Table 20. Becton, Dickinson Company Information, Head Office, and Major Competitors
Table 21. Becton, Dickinson Major Business
Table 22. Becton, Dickinson Sepsis Diagnostics Product and Solutions
Table 23. Becton, Dickinson Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Becton, Dickinson Recent Developments and Future Plans
Table 25. Roche Company Information, Head Office, and Major Competitors
Table 26. Roche Major Business
Table 27. Roche Sepsis Diagnostics Product and Solutions
Table 28. Roche Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Roche Recent Developments and Future Plans
Table 30. Danaher Company Information, Head Office, and Major Competitors
Table 31. Danaher Major Business
Table 32. Danaher Sepsis Diagnostics Product and Solutions
Table 33. Danaher Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Danaher Recent Developments and Future Plans
Table 35. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Major Business
Table 37. Thermo Fisher Sepsis Diagnostics Product and Solutions
Table 38. Thermo Fisher Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Thermo Fisher Recent Developments and Future Plans
Table 40. Bruker Company Information, Head Office, and Major Competitors
Table 41. Bruker Major Business
Table 42. Bruker Sepsis Diagnostics Product and Solutions
Table 43. Bruker Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bruker Recent Developments and Future Plans
Table 45. Abbott Company Information, Head Office, and Major Competitors
Table 46. Abbott Major Business
Table 47. Abbott Sepsis Diagnostics Product and Solutions
Table 48. Abbott Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Abbott Recent Developments and Future Plans
Table 50. Immunexpress Company Information, Head Office, and Major Competitors
Table 51. Immunexpress Major Business
Table 52. Immunexpress Sepsis Diagnostics Product and Solutions
Table 53. Immunexpress Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Immunexpress Recent Developments and Future Plans
Table 55. Response Biomedical Company Information, Head Office, and Major Competitors
Table 56. Response Biomedical Major Business
Table 57. Response Biomedical Sepsis Diagnostics Product and Solutions
Table 58. Response Biomedical Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Response Biomedical Recent Developments and Future Plans
Table 60. Axis-Shield Diagnostics Company Information, Head Office, and Major Competitors
Table 61. Axis-Shield Diagnostics Major Business
Table 62. Axis-Shield Diagnostics Sepsis Diagnostics Product and Solutions
Table 63. Axis-Shield Diagnostics Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Axis-Shield Diagnostics Recent Developments and Future Plans
Table 65. Cytosorbents Company Information, Head Office, and Major Competitors
Table 66. Cytosorbents Major Business
Table 67. Cytosorbents Sepsis Diagnostics Product and Solutions
Table 68. Cytosorbents Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Cytosorbents Recent Developments and Future Plans
Table 70. Mitsubishi Chemical Company Information, Head Office, and Major Competitors
Table 71. Mitsubishi Chemical Major Business
Table 72. Mitsubishi Chemical Sepsis Diagnostics Product and Solutions
Table 73. Mitsubishi Chemical Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Mitsubishi Chemical Recent Developments and Future Plans
Table 75. EKF Diagnostics Company Information, Head Office, and Major Competitors
Table 76. EKF Diagnostics Major Business
Table 77. EKF Diagnostics Sepsis Diagnostics Product and Solutions
Table 78. EKF Diagnostics Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. EKF Diagnostics Recent Developments and Future Plans
Table 80. Global Sepsis Diagnostics Revenue (USD Million) by Players (2019-2024)
Table 81. Global Sepsis Diagnostics Revenue Share by Players (2019-2024)
Table 82. Breakdown of Sepsis Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Sepsis Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key Sepsis Diagnostics Players
Table 85. Sepsis Diagnostics Market: Company Product Type Footprint
Table 86. Sepsis Diagnostics Market: Company Product Application Footprint
Table 87. Sepsis Diagnostics New Market Entrants and Barriers to Market Entry
Table 88. Sepsis Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Sepsis Diagnostics Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global Sepsis Diagnostics Consumption Value Share by Type (2019-2024)
Table 91. Global Sepsis Diagnostics Consumption Value Forecast by Type (2025-2030)
Table 92. Global Sepsis Diagnostics Consumption Value by Application (2019-2024)
Table 93. Global Sepsis Diagnostics Consumption Value Forecast by Application (2025-2030)
Table 94. North America Sepsis Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America Sepsis Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America Sepsis Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America Sepsis Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America Sepsis Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America Sepsis Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe Sepsis Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe Sepsis Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe Sepsis Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe Sepsis Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe Sepsis Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Sepsis Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Sepsis Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific Sepsis Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific Sepsis Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific Sepsis Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific Sepsis Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific Sepsis Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America Sepsis Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America Sepsis Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America Sepsis Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America Sepsis Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America Sepsis Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Sepsis Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Sepsis Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa Sepsis Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa Sepsis Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa Sepsis Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa Sepsis Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa Sepsis Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 124. Sepsis Diagnostics Raw Material
Table 125. Key Suppliers of Sepsis Diagnostics Raw Materials
Table 1. Global Sepsis Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Sepsis Diagnostics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Sepsis Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Sepsis Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Biomerieux Company Information, Head Office, and Major Competitors
Table 6. Biomerieux Major Business
Table 7. Biomerieux Sepsis Diagnostics Product and Solutions
Table 8. Biomerieux Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Biomerieux Recent Developments and Future Plans
Table 10. T2 Biosystems Company Information, Head Office, and Major Competitors
Table 11. T2 Biosystems Major Business
Table 12. T2 Biosystems Sepsis Diagnostics Product and Solutions
Table 13. T2 Biosystems Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. T2 Biosystems Recent Developments and Future Plans
Table 15. Luminex Company Information, Head Office, and Major Competitors
Table 16. Luminex Major Business
Table 17. Luminex Sepsis Diagnostics Product and Solutions
Table 18. Luminex Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Luminex Recent Developments and Future Plans
Table 20. Becton, Dickinson Company Information, Head Office, and Major Competitors
Table 21. Becton, Dickinson Major Business
Table 22. Becton, Dickinson Sepsis Diagnostics Product and Solutions
Table 23. Becton, Dickinson Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Becton, Dickinson Recent Developments and Future Plans
Table 25. Roche Company Information, Head Office, and Major Competitors
Table 26. Roche Major Business
Table 27. Roche Sepsis Diagnostics Product and Solutions
Table 28. Roche Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Roche Recent Developments and Future Plans
Table 30. Danaher Company Information, Head Office, and Major Competitors
Table 31. Danaher Major Business
Table 32. Danaher Sepsis Diagnostics Product and Solutions
Table 33. Danaher Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Danaher Recent Developments and Future Plans
Table 35. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Major Business
Table 37. Thermo Fisher Sepsis Diagnostics Product and Solutions
Table 38. Thermo Fisher Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Thermo Fisher Recent Developments and Future Plans
Table 40. Bruker Company Information, Head Office, and Major Competitors
Table 41. Bruker Major Business
Table 42. Bruker Sepsis Diagnostics Product and Solutions
Table 43. Bruker Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Bruker Recent Developments and Future Plans
Table 45. Abbott Company Information, Head Office, and Major Competitors
Table 46. Abbott Major Business
Table 47. Abbott Sepsis Diagnostics Product and Solutions
Table 48. Abbott Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Abbott Recent Developments and Future Plans
Table 50. Immunexpress Company Information, Head Office, and Major Competitors
Table 51. Immunexpress Major Business
Table 52. Immunexpress Sepsis Diagnostics Product and Solutions
Table 53. Immunexpress Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Immunexpress Recent Developments and Future Plans
Table 55. Response Biomedical Company Information, Head Office, and Major Competitors
Table 56. Response Biomedical Major Business
Table 57. Response Biomedical Sepsis Diagnostics Product and Solutions
Table 58. Response Biomedical Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Response Biomedical Recent Developments and Future Plans
Table 60. Axis-Shield Diagnostics Company Information, Head Office, and Major Competitors
Table 61. Axis-Shield Diagnostics Major Business
Table 62. Axis-Shield Diagnostics Sepsis Diagnostics Product and Solutions
Table 63. Axis-Shield Diagnostics Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Axis-Shield Diagnostics Recent Developments and Future Plans
Table 65. Cytosorbents Company Information, Head Office, and Major Competitors
Table 66. Cytosorbents Major Business
Table 67. Cytosorbents Sepsis Diagnostics Product and Solutions
Table 68. Cytosorbents Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Cytosorbents Recent Developments and Future Plans
Table 70. Mitsubishi Chemical Company Information, Head Office, and Major Competitors
Table 71. Mitsubishi Chemical Major Business
Table 72. Mitsubishi Chemical Sepsis Diagnostics Product and Solutions
Table 73. Mitsubishi Chemical Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Mitsubishi Chemical Recent Developments and Future Plans
Table 75. EKF Diagnostics Company Information, Head Office, and Major Competitors
Table 76. EKF Diagnostics Major Business
Table 77. EKF Diagnostics Sepsis Diagnostics Product and Solutions
Table 78. EKF Diagnostics Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. EKF Diagnostics Recent Developments and Future Plans
Table 80. Global Sepsis Diagnostics Revenue (USD Million) by Players (2019-2024)
Table 81. Global Sepsis Diagnostics Revenue Share by Players (2019-2024)
Table 82. Breakdown of Sepsis Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Sepsis Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key Sepsis Diagnostics Players
Table 85. Sepsis Diagnostics Market: Company Product Type Footprint
Table 86. Sepsis Diagnostics Market: Company Product Application Footprint
Table 87. Sepsis Diagnostics New Market Entrants and Barriers to Market Entry
Table 88. Sepsis Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Sepsis Diagnostics Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global Sepsis Diagnostics Consumption Value Share by Type (2019-2024)
Table 91. Global Sepsis Diagnostics Consumption Value Forecast by Type (2025-2030)
Table 92. Global Sepsis Diagnostics Consumption Value by Application (2019-2024)
Table 93. Global Sepsis Diagnostics Consumption Value Forecast by Application (2025-2030)
Table 94. North America Sepsis Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America Sepsis Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America Sepsis Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America Sepsis Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America Sepsis Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America Sepsis Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe Sepsis Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe Sepsis Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe Sepsis Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe Sepsis Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe Sepsis Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Sepsis Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Sepsis Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific Sepsis Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific Sepsis Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific Sepsis Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific Sepsis Diagnostics Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific Sepsis Diagnostics Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America Sepsis Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America Sepsis Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America Sepsis Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America Sepsis Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America Sepsis Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Sepsis Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Sepsis Diagnostics Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa Sepsis Diagnostics Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa Sepsis Diagnostics Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa Sepsis Diagnostics Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa Sepsis Diagnostics Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa Sepsis Diagnostics Consumption Value by Country (2025-2030) & (USD Million)
Table 124. Sepsis Diagnostics Raw Material
Table 125. Key Suppliers of Sepsis Diagnostics Raw Materials
LIST OF FIGURES
Figure 1. Sepsis Diagnostics Picture
Figure 2. Global Sepsis Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Sepsis Diagnostics Consumption Value Market Share by Type in 2023
Figure 4. Microbiology
Figure 5. Molecular Diagnostics
Figure 6. Immunoassays
Figure 7. Flow Cytometry
Figure 8. Microfluidics
Figure 9. Biomarkers
Figure 10. Global Sepsis Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Sepsis Diagnostics Consumption Value Market Share by Application in 2023
Figure 12. Hospitals Picture
Figure 13. Pathology & Reference Laboratories Picture
Figure 14. Global Sepsis Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Sepsis Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Sepsis Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Sepsis Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Sepsis Diagnostics Consumption Value Market Share by Region in 2023
Figure 19. North America Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Sepsis Diagnostics Revenue Share by Players in 2023
Figure 25. Sepsis Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Sepsis Diagnostics Market Share in 2023
Figure 27. Global Top 6 Players Sepsis Diagnostics Market Share in 2023
Figure 28. Global Sepsis Diagnostics Consumption Value Share by Type (2019-2024)
Figure 29. Global Sepsis Diagnostics Market Share Forecast by Type (2025-2030)
Figure 30. Global Sepsis Diagnostics Consumption Value Share by Application (2019-2024)
Figure 31. Global Sepsis Diagnostics Market Share Forecast by Application (2025-2030)
Figure 32. North America Sepsis Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Sepsis Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Sepsis Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Sepsis Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Sepsis Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Sepsis Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 42. France Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Sepsis Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Sepsis Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Sepsis Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 49. China Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 52. India Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Sepsis Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Sepsis Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Sepsis Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Sepsis Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Sepsis Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Sepsis Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 66. Sepsis Diagnostics Market Drivers
Figure 67. Sepsis Diagnostics Market Restraints
Figure 68. Sepsis Diagnostics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Sepsis Diagnostics in 2023
Figure 71. Manufacturing Process Analysis of Sepsis Diagnostics
Figure 72. Sepsis Diagnostics Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Sepsis Diagnostics Picture
Figure 2. Global Sepsis Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Sepsis Diagnostics Consumption Value Market Share by Type in 2023
Figure 4. Microbiology
Figure 5. Molecular Diagnostics
Figure 6. Immunoassays
Figure 7. Flow Cytometry
Figure 8. Microfluidics
Figure 9. Biomarkers
Figure 10. Global Sepsis Diagnostics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Sepsis Diagnostics Consumption Value Market Share by Application in 2023
Figure 12. Hospitals Picture
Figure 13. Pathology & Reference Laboratories Picture
Figure 14. Global Sepsis Diagnostics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Sepsis Diagnostics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Sepsis Diagnostics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Sepsis Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Sepsis Diagnostics Consumption Value Market Share by Region in 2023
Figure 19. North America Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Sepsis Diagnostics Revenue Share by Players in 2023
Figure 25. Sepsis Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Sepsis Diagnostics Market Share in 2023
Figure 27. Global Top 6 Players Sepsis Diagnostics Market Share in 2023
Figure 28. Global Sepsis Diagnostics Consumption Value Share by Type (2019-2024)
Figure 29. Global Sepsis Diagnostics Market Share Forecast by Type (2025-2030)
Figure 30. Global Sepsis Diagnostics Consumption Value Share by Application (2019-2024)
Figure 31. Global Sepsis Diagnostics Market Share Forecast by Application (2025-2030)
Figure 32. North America Sepsis Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Sepsis Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Sepsis Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Sepsis Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Sepsis Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Sepsis Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 42. France Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Sepsis Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Sepsis Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Sepsis Diagnostics Consumption Value Market Share by Region (2019-2030)
Figure 49. China Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 52. India Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Sepsis Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Sepsis Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Sepsis Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Sepsis Diagnostics Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Sepsis Diagnostics Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Sepsis Diagnostics Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Sepsis Diagnostics Consumption Value (2019-2030) & (USD Million)
Figure 66. Sepsis Diagnostics Market Drivers
Figure 67. Sepsis Diagnostics Market Restraints
Figure 68. Sepsis Diagnostics Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Sepsis Diagnostics in 2023
Figure 71. Manufacturing Process Analysis of Sepsis Diagnostics
Figure 72. Sepsis Diagnostics Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
